Selinexor suppresses downstream effectors of B-cell activation, proliferation and migration in chronic lymphocytic leukemia cells

Leukemia. 2014 May;28(5):1158-63. doi: 10.1038/leu.2014.9. Epub 2014 Jan 13.

¹ Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
² Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, USA.
³ Center for Biostatistics, The Ohio State University, Columbus, OH, USA.
⁴ Karyopharm Therapeutics Inc., Natick, MA, USA.
⁵ 1] Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA [2] Division of Medicinal Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH, USA.

No abstract available

Publication types